All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
HONG KONG – South Korean pharmaceutical major Green Cross Corp. is expanding its cell therapy business to China's Guizhou Province, where the local government has welcomed the investment in an emerging new therapeutic area with great potential.